Net Loss of Brawn Biotech reported to Rs 0.34 crore in the quarter ended September 2024 as against net loss of Rs 0.42 crore during the previous quarter ended September 2023. Sales rose 13.01% to Rs 3.30 crore in the quarter ended September 2024 as against Rs 2.92 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.302.92 13 OPM %-9.39-13.36 - PBDT-0.31-0.39 21 PBT-0.34-0.42 19 NP-0.34-0.42 19 Powered by Capital Market - Live News

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Net Loss of Brawn Biotech reported to Rs 0.53 crore in the quarter ended June 2024 as against net loss of Rs 0.17 crore during the previous quarter ended June 2023. Sales declined 44.31% to Rs 4.06 crore in the quarter ended June 2024 as against Rs 7.29 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales4.067.29 -44 OPM %-12.32-2.06 - PBDT-0.50-0.15 -233 PBT-0.53-0.17 -212 NP-0.53-0.17 -212 Powered by Capital Market - Live News

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live News